Shirasaki H et al. |
The effect of a cysteinyl leukotriene antagonist, ONO-1078 (pranlukast) on agonist- and antigen-induced nasal microvascular leakage in guinea pigs. |
1998 |
Rhinology |
pmid:9695159
|
Tohda Y et al. |
Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. |
2001 |
Respiration |
pmid:11223734
|
Ahmed T et al. |
Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence. |
2012 |
Respir. Res. |
pmid:22269021
|
Rovati GE et al. |
Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma. |
2006 |
Respir. Res. |
pmid:16875498
|
Ravasi S et al. |
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation. |
2006 |
Respir. Res. |
pmid:16553950
|
Yamaya M et al. |
Dipeptidase inhibitor and epithelial removal potentiate leukotriene D4-induced human tracheal smooth muscle contraction. |
1998 |
Respir Physiol |
pmid:9496476
|
Laberge S et al. |
Antigen-induced airway inflammation and hyper-responsiveness does not enhance airway responses to a subsequent antigen challenge in rats. |
2000 |
Respir Med |
pmid:10714478
|
Kivity S et al. |
Eosinophil influx into the airways in patients with exercise-induced asthma. |
2000 |
Respir Med |
pmid:11192956
|
Lane SJ |
Leukotriene antagonism in asthma and rhinitis. |
1998 |
Respir Med |
pmid:9850362
|
Guan WJ et al. |
Impulse oscillometry for leukotriene D4 inhalation challenge in asthma. |
2013 |
Respir Care |
pmid:23716710
|
Capra V and Rovati GE |
Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents. |
2014 |
Pulm Pharmacol Ther |
pmid:23806820
|
Turner DJ et al. |
Bradykinin-induced airway constriction in guinea-pigs: role of leukotriene D(4). |
2000 |
Pulm Pharmacol Ther |
pmid:10930357
|
Skogvall S et al. |
Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants. |
2007 |
Pulm Pharmacol Ther |
pmid:16731017
|
Pitt CM and Nally JE |
Angiotensin II-mediated potentiation of endothelin-1-evoked bronchial contractions: a role for leukotrienes? |
1999 |
Pulm Pharmacol Ther |
pmid:10208831
|
Skogvall S et al. |
Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95. |
2008 |
Pulm Pharmacol Ther |
pmid:17374498
|
Yang XX et al. |
The beta(2)-agonist salbutamol inhibits bronchoconstriction and leukotriene D(4) synthesis after dry gas hyperpnea in the guinea-pig. |
1999 |
Pulm Pharmacol Ther |
pmid:10545287
|
Schelfhout V et al. |
The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction. |
2008 |
Pulm Pharmacol Ther |
pmid:17611132
|
Abraham WM et al. |
Effect of TYB-2285 on antigen-induced airway responses in sheep. |
1996 |
Pulm Pharmacol |
pmid:8843510
|
Callaghan DH et al. |
Respiratory tract eicosanoid measurement using microdialysis sampling and GC/MS detection. |
1994 |
Pulm Pharmacol |
pmid:8003850
|
Madsen F et al. |
Challenge interval determines tachyphylaxis to aerosolized LTD4. |
1995 |
Pulm Pharmacol |
pmid:8819178
|